A journalist, a soup exec, and an imam walk into a room. There’s no joke here. It’s just another day at CrisprCon. On Monday and Tuesday, hundreds of scientists, industry folk, and public health officials from all over the world filled the amphitheater at the Boston World Trade Center to reckon with the power of biology’s favorite new DNA-tinkering tool: Crispr.